Arbutus Biopharma Corporation
Status: Publicly traded
Direct answer
Arbutus Biopharma Corporation is publicly traded on NASDAQ under the ticker ABUS.
Arbutus Biopharma Corporation, a biopharmaceutical company operating in the United States, focuses on the discovery and development of novel therapies for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. Central to its HBV product portfolio is AB-729, an innovative RNA interference product candidate delivered subcutaneously. Currently undergoing Phase Ia/Ib clinical trials, AB-729 is...
Can you invest in Arbutus Biopharma Corporation?
Yes. Arbutus Biopharma Corporation is publicly traded on NASDAQ under the ticker ABUS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Arbutus Biopharma Corporation
Detailed equity research is provided by MarketSnap.